microRNA 4511 (MIR4511)

microRNA 4511 (MIR4511) is a small non-coding RNA classified as a microRNA, part of a large family of endogenous RNAs that play crucial roles in post-transcriptional regulation of gene expression by binding to target mRNAs and promoting their degradation or inhibiting their translation[1][2][3]. MicroRNAs in general are processed from precursor transcripts through a series of enzymatic steps involving the microprocessor complex (including DROSHA and DGCR8) and DICER, and then assembled into the RNA-induced silencing complex (RISC), where they guide gene silencing. While many human microRNAs have documented roles in cellular processes and disease, there are no curated, peer-reviewed data sources indicating that MIR4511 itself functions as a receptor, enzyme, transporter, or established therapeutic target. There is no evidence for involvement of MIR4511 in specific biological pathways, diseases, or drug interactions based on current scientific databases and reviews[1][2][3]. It should be noted that "microRNA 4511" corresponds to a typical naming convention for microRNAs, but is highly likely to represent either an obscure or minimally studied RNA species, or potentially a mis-annotation, as there is no readily available structured or functional information for MIR4511 in recognized sources. Note on correctness: There is insufficient evidence to confirm that MIR4511 is a well-characterized molecular target or therapeutic receptor. No data on disease associations, biological functions, or drug interactions are available in authoritative reviews. This suggests the name may be incorrect or insufficiently established as a therapeutic target. Summary conventions applied: - “microRNA 4511” is the full standardized name for MIR4511. - microRNAs are classified outside canonical target groups such as receptors or enzymes[2][3]. - No evidence for MIR4511 as a specific disease biomarker, therapeutic target, or drug-interacting molecule. - No safety concerns, mechanisms, or biomarkers identified due to lack of supporting data. If further details or disease associations for MIR4511 are needed, more specialized or narrowly focused literature searches would be required. Currently, MIR4511 is not considered a validated molecular drug target.

Other names

hsa-mir-4511mir-4511MIR4511